Published in JAMA on May 03, 1995
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology (1999) 9.86
Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health (1998) 9.58
The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology (2008) 5.94
Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology (2013) 4.80
National estimates of the prevalence of Alzheimer's disease in the United States. Alzheimers Dement (2011) 3.42
Role of the neuropathology of Alzheimer disease in dementia in the oldest-old. Arch Neurol (2008) 1.93
The incidence of dementia in England and Wales: findings from the five identical sites of the MRC CFA Study. PLoS Med (2005) 1.86
Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.78
Alzheimer disease. Dis Mon (2010) 1.64
Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends Neurosci (2011) 1.51
Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia. Arch Gen Psychiatry (2009) 1.44
Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Hum Genet (1996) 1.30
Nuanced roles of cytokines in three major human brain disorders. J Clin Invest (2008) 1.28
Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 2. Alzheimers Dement (2011) 1.19
Smoking, drinking, and incident cognitive impairment: a cohort community based study included in the Gospel Oak project. J Neurol Neurosurg Psychiatry (2000) 1.19
Epidemiology of the dementias: recent developments and new approaches. J Neurol Neurosurg Psychiatry (1996) 1.12
Change in risk of Alzheimer disease over time. Neurology (2010) 1.11
Physical activity attenuates age-related biomarker alterations in preclinical AD. Neurology (2014) 1.10
Ubiquitin conjugation triggers misfolded protein sequestration into quality control foci when Hsp70 chaperone levels are limiting. Mol Biol Cell (2013) 1.07
Rates of decline in Alzheimer disease decrease with age. PLoS One (2012) 1.07
Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers. PLoS One (2011) 1.07
Test-retest stability on the WRAT-3 reading subtest in geriatric cognitive evaluations. J Clin Exp Neuropsychol (2008) 1.06
Age-correlated gene expression in normal and neurodegenerative human brain tissues. PLoS One (2010) 1.06
Brain volumes, cognitive impairment, and conjugated equine estrogens. J Gerontol A Biol Sci Med Sci (2009) 1.05
Heart failure with preserved ejection fraction in the elderly: scope of the problem. Heart Fail Rev (2012) 1.04
Economic considerations in the management of Alzheimer's disease. Clin Interv Aging (2006) 1.03
Antioxidant therapies for Alzheimer's disease. Oxid Med Cell Longev (2012) 1.03
Prevalence of psychiatric morbidity amongst the community dwelling rural older adults in northern India. Indian J Med Res (2013) 0.97
Children of persons with Alzheimer disease: what does the future hold? Alzheimer Dis Assoc Disord (2008) 0.97
Chaperoning proteins for destruction: diverse roles of Hsp70 chaperones and their co-chaperones in targeting misfolded proteins to the proteasome. Biomolecules (2014) 0.95
Identifying families with likely genetic protective factors against Alzheimer disease. Am J Hum Genet (1999) 0.95
Effects of a cognitive-enhancement group training program on daily living activities, cognition, and depression in the demented elderly. J Phys Ther Sci (2015) 0.94
Hormonal influences on cognition and risk for Alzheimer's disease. Curr Neurol Neurosci Rep (2010) 0.94
Alzheimer Aβ disrupts the mitotic spindle and directly inhibits mitotic microtubule motors. Cell Cycle (2011) 0.94
Memory loss in Alzheimer's disease. Dialogues Clin Neurosci (2013) 0.94
Polysomnographic and subjective sleep markers of mild cognitive impairment. Sleep (2013) 0.93
Challenges and opportunities for developing and implementing incentives to improve health-related behaviors in older adults. J Am Geriatr Soc (2010) 0.91
Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline. J Neurol Neurosurg Psychiatry (2004) 0.90
The prediction and prevention of Alzheimer's disease--towards a research agenda. J Psychiatry Neurosci (1999) 0.90
In vivo imaging of axonal transport of mitochondria in the diseased and aged mammalian CNS. Proc Natl Acad Sci U S A (2015) 0.90
Dementia and hip fractures: development of a pathogenic framework for understanding and studying risk. Geriatr Orthop Surg Rehabil (2010) 0.87
Anticholinesterase activities of cold and hot aqueous extracts of F. racemosa stem bark. Pharmacogn Mag (2010) 0.86
Concepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application. Int J Exp Pathol (2005) 0.85
Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease. JAMA Neurol (2015) 0.85
Diagnosis and treatment of osteoporosis in high-risk patients prior to hip fracture. Geriatr Orthop Surg Rehabil (2012) 0.82
Memory activation in healthy nonagenarians. Neurobiol Aging (2009) 0.81
Dementia / Alzheimer's Disease. BMC Womens Health (2004) 0.81
Qualitative neuropsychological measures: normative data on executive functioning tests from the Framingham offspring study. Exp Aging Res (2013) 0.80
Perspectives in molecular imaging using staging biomarkers and immunotherapies in Alzheimer's disease. ScientificWorldJournal (2013) 0.78
Correlation of Alzheimer's disease death rates with historical per capita personal income in the USA. PLoS One (2015) 0.78
Adding memantine to rivastigmine therapy in patients with mild-to-moderate alzheimer's disease: results of a 12-week, open-label pilot study. Prim Care Companion J Clin Psychiatry (2006) 0.78
A preliminary investigation of anticholinesterase activity of some Iranian medicinal plants commonly used in traditional medicine. Daru (2014) 0.78
Breaking up (amyloid) is hard to do. PLoS Med (2005) 0.77
Predictors of Optimal Cognitive Aging in 80+ Women: The Women's Health Initiative Memory Study. J Gerontol A Biol Sci Med Sci (2016) 0.77
The Vallecas Project: A Cohort to Identify Early Markers and Mechanisms of Alzheimer's Disease. Front Aging Neurosci (2015) 0.77
The association between mental health and cognitive screening scores in older veterans. Am J Geriatr Psychiatry (2012) 0.77
Impact of neuroprotection on incidence of Alzheimer's disease. PLoS One (2006) 0.77
Association of the interleukin 1 beta gene and brain spontaneous activity in amnestic mild cognitive impairment. J Neuroinflammation (2012) 0.77
Alzheimer's disease: Current Trends in Wales. Oman Med J (2014) 0.76
Cardiorespiratory fitness alters the influence of a polygenic risk score on biomarkers of AD. Neurology (2017) 0.75
What does it take to stay healthy past 100?: Commentary on "No disease in the brain of a 115-year-old woman". Neurobiol Aging (2008) 0.75
Cheap solutions for big problems? Br J Sports Med (2007) 0.75
Gonadal hormones modulate the potency of the disruptive effects of donepezil in male rats responding under a nonspatial operant learning and performance task. Behav Pharmacol (2010) 0.75
A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol (1994) 30.72
Two shorter forms of the CES-D (Center for Epidemiological Studies Depression) depression symptoms index. J Aging Health (1993) 11.92
Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol (2001) 9.96
Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA (1989) 8.36
Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet (1998) 7.26
Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology (2009) 7.04
Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol (2000) 6.40
An improved and simplified method of detecting the acetylator phenotype. J Med Genet (1969) 6.40
Natural history of mild cognitive impairment in older persons. Neurology (2002) 6.09
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology (2005) 5.76
A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. J Med Genet (1980) 5.68
Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord (2001) 5.09
Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group. Antimicrob Agents Chemother (1993) 4.96
MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology (2002) 4.67
MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging (2001) 4.54
Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci (1991) 4.53
Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. Br Med J (1969) 4.21
Latent Semantic Indexing of medical diagnoses using UMLS semantic structures. Proc Annu Symp Comput Appl Med Care (1991) 4.09
Measuring health-related quality of life for public health surveillance. Public Health Rep (1994) 4.08
Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology (2004) 4.00
Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology (2005) 3.90
Maintaining mobility in late life. I. Demographic characteristics and chronic conditions. Am J Epidemiol (1993) 3.74
Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology (2004) 3.61
Preclinical prediction of Alzheimer's disease using SPECT. Neurology (1998) 3.60
Nomenclature for N-acetyltransferases. Pharmacogenetics (1995) 3.59
Proneness to psychological distress is associated with risk of Alzheimer's disease. Neurology (2003) 3.59
Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med (1996) 3.48
Established populations for epidemiologic studies of the elderly: study design and methodology. Aging (Milano) (1993) 3.47
Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology (2002) 3.40
Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg Br (1982) 3.39
Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology (2003) 3.35
Relation of cognitive activity to risk of developing Alzheimer disease. Neurology (2007) 3.34
Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA (1997) 3.17
ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology (1997) 3.04
Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med (1992) 2.92
Cognitive activity and incident AD in a population-based sample of older persons. Neurology (2002) 2.77
Depressive symptoms and cognitive decline in a community population of older persons. J Neurol Neurosurg Psychiatry (2004) 2.67
A prospective study of incident comprehensive medical home care use among the elderly. Am J Public Health (1988) 2.67
Social resources and cognitive decline in a population of older African Americans and whites. Neurology (2004) 2.66
Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology (2003) 2.60
fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry (2003) 2.49
Change in body mass index and risk of incident Alzheimer disease. Neurology (2005) 2.48
Broca aphasia: pathologic and clinical. Neurology (1978) 2.43
Cognitive decline in incident Alzheimer disease in a community population. Neurology (2010) 2.41
Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology (2003) 2.32
Cognitive activity in older persons from a geographically defined population. J Gerontol B Psychol Sci Soc Sci (1999) 2.31
Correlates of cognitive function in an elderly community population. Am J Epidemiol (1988) 2.26
Detection of cortical thickness correlates of cognitive performance: Reliability across MRI scan sessions, scanners, and field strengths. Neuroimage (2007) 2.23
Chiral bis(oxazoline) copper(II) complexes: versatile catalysts for enantioselective cycloaddition, Aldol, Michael, and carbonyl ene reactions. Acc Chem Res (2000) 2.22
Age of Neoproterozoic bilatarian body and trace fossils, White Sea, Russia: implications for metazoan evolution. Science (2000) 2.21
Terminal decline in cognitive function. Neurology (2003) 2.18
Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol (1993) 2.17
Encoding novel face-name associations: a functional MRI study. Hum Brain Mapp (2001) 2.13
Conscious recollection and the human hippocampal formation: evidence from positron emission tomography. Proc Natl Acad Sci U S A (1996) 2.09
Low-dose aspirin for migraine prophylaxis in women. Cephalalgia (2001) 2.07
Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. Arch Neurol (1997) 2.07
Cognitive activity and cognitive decline in a biracial community population. Neurology (2003) 2.06
Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology (2008) 1.97
Level of education and change in cognitive function in a community population of older persons. Ann Epidemiol (1993) 1.96
White matter changes with normal aging. Neurology (1998) 1.95
Epidemiology of disability in the oldest old: methodologic issues and preliminary findings. Milbank Mem Fund Q Health Soc (1985) 1.94
Cadaveric study of movement of an unstable atlanto-axial (C1/C2) cervical segment during laryngoscopy and intubation using the Airtraq(®) , Macintosh and McCoy laryngoscopes. Anaesthesia (2014) 1.93
Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations. Pharmacogenetics (1997) 1.92
The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions. J Med Genet (1983) 1.92
Trypanosoma brucei: Miniature anion-exchange centrifugation technique for detection of low parasitaemias: Adaptation for field use. Trans R Soc Trop Med Hyg (1979) 1.92
Acute delirium and functional decline in the hospitalized elderly patient. J Gerontol (1993) 1.91
Temporal course of depressive symptoms during the development of Alzheimer disease. Neurology (2010) 1.87
Analysis of change in self-reported physical function among older persons in four population studies. Am J Epidemiol (1996) 1.86
The actylation of sulamethazine and sulfamethoxypyridazine by human subjects. Clin Pharmacol Ther (1968) 1.85
Sputum examination for the diagnosis of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Am Rev Respir Dis (1986) 1.84
Cognitive decline after hospitalization in a community population of older persons. Neurology (2012) 1.83
Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology (2011) 1.83
Empirical, automated vocabulary discovery using large text corpora and advanced natural language processing tools. Proc AMIA Annu Fall Symp (1996) 1.81